Loop Industries, Inc. Income Taxes Disclosure
22. Income Taxes
The components of the Company’s loss before taxes are summarized below:
| February 28, | February 28, | |||||||
| 2026 | 2025 | |||||||
| U.S. operations | $ | (5,500 | ) | $ | (6,049 | ) | ||
| Foreign operations | (6,799 | ) | (9,008 | ) | ||||
| Loss before taxes | $ | (12,299 | ) | $ | (15,057 | ) | ||
A reconciliation from the statutory U.S. income tax rate and the Company’s effective income tax rate, as computed on loss before taxes, is as follows:
| February 28, | February 28,
| |||||||||||||||
| 2026
| 2025
| |||||||||||||||
| Rate | Amount | Rate | Amount | |||||||||||||
| Federal income tax at statutory rate | % | $ | % | $ | ) | |||||||||||
| Effect of Canadian foreign jurisdiction taxed at a different rate | 2 | 3 | (410 | ) | ||||||||||||
| Non-deductible expenses - Accretion expenses and other | 27 | 77 | ||||||||||||||
| Non-deductible expenses - Stock-based compensation | ) | 216 | 207 | |||||||||||||
| Non-deductible expenses - Imputed interest income from intercompany loan | ) | 1,130 | 1,357 | |||||||||||||
| Non-deductible expenses - Loss pick-up from equity method investments | (1 | ) | 160 | - | - | |||||||||||
| Tax credits related to research and development expenditures - Current year | 2 | 2 | (255 | ) | ||||||||||||
| Tax credits related to research and development expenditures - True up prior year | - | 1 | ||||||||||||||
| Non-Cash dividend related to the Series B CPS | (2 | ) | 296 | - | - | |||||||||||
| Effect of prior year true-up | (2 | ) | 261 | - | 45 | |||||||||||
| Change in valuation allowance | ) | 1,041 | 2,226 | |||||||||||||
| Effective income tax expense | % | - | $ | - | % | - | $ | - | ||||||||
| Current | % | - | $ | - | % | - | $ | - | ||||||||
| Deferred | % | - | $ | - | % | - | $ | - | ||||||||
The state and local taxes are not included within the rate reconciliation or the current and deferred breakdown above as the amounts relating to the year ended February 28, 2026 are (2025-).
The Company has net operating loss carry forwards of approximately $32,689 (2025 – $36,285) for U.S. Federal income tax purposes expiring between 2035 and 2038, post 2018 net operating losses may be carried forward indefinitely. The Company has net operating loss carry forwards for Canadian Federal and Québec tax purposes of approximately $84,610 (), 2025 - $80,560 (), and $91,006 (), 2025 - $86,816 (), respectively, expiring between 2037 and 2046. Realization of future tax assets is dependent on future earnings, the timing and amount of which are uncertain. Accordingly, the net future tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $1,848 and $1,260, respectively, for the years ended February 28, 2026 and February 28, 2025. The Company has provided a full valuation allowance on the deferred tax assets as a result of the uncertainty regarding the probability of its realization.
The Company has approximately $12,378 (), 2025 - $10,517 () of research and development expenditures for Canadian Federal and Québec provincial purposes that are available to reduce taxable income in future years and have an unlimited carry forward period, the benefit of which has not been reflected in these financial statements. Research and development expenditures are subject to audit by the taxation authorities and accordingly, these amounts may vary.
The tax effect of temporary differences between US GAAP accounting and federal income tax accounting creating deferred income tax assets and liabilities were as follows:
| As at | ||||||||
| February 28, | February 28, | |||||||
| 2026 | 2025 | |||||||
| Deferred tax assets | ||||||||
| Canada net operating loss carry forward | $ | 22,974 | $ | 20,703 | ||||
| U.S. net operating loss carry forward | 6,865 | 7,620 | ||||||
| Accrual and reserves | 879 | 691 | ||||||
| Intangibles | 336 | 357 | ||||||
| Property, plant and equipment | 4,379 | 4,115 | ||||||
| Research and development expenditures and credits | 5,531 | 4,745 | ||||||
| Basis in partnership | 235 | 235 | ||||||
| Other | 959 | 1,828 | ||||||
| Deferred tax assets | 42,158 | 40,294 | ||||||
| Deferred tax liabilities | ||||||||
| Intangibles | (469 | ) | (453 | ) | ||||
| Deferred tax liabilities | $ | (469 | ) | $ | (453 | ) | ||
| Deferred tax assets, net | 41,689 | 39,841 | ||||||
| Valuation allowance | (41,689 | ) | (39,841 | ) | ||||
| Deferred tax assets, net | $ | - | $ | - | ||||
Assessment of the amount of value assigned to the Company's deferred tax assets under the applicable accounting rules is judgmental. The Company is required to consider all available positive and negative evidence in evaluating the likelihood that the Company will be able to realize the benefit of its deferred tax assets in the future. Such evidence includes scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and the results of recent operations. Since this evaluation requires consideration of events that may occur some years into the future, there is an element of judgment involved. Realization of the Company's deferred tax assets is dependent on generating sufficient taxable income in future periods. Management does not believe that it is more likely than not that future taxable income will be sufficient to allow it to recover substantially all of the value assigned to its deferred tax assets. Accordingly, the Company has provided for a valuation allowance of the Company's deferred tax asset.
The income taxes paid for federal, state, and Canadian foreign jurisdiction for the year ended February 28, 2026 were ().
The tax years subject to examination by major tax jurisdiction include the years ending and forward by the U.S. Internal Revenue Service and most state jurisdictions, and the years and forward for the Canadian jurisdiction.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | May 27, 2026 | Showing above |
| 2025 | May 29, 2025 | |
| 2024 | May 29, 2024 | |
| 2023 | May 18, 2023 | |
| 2022 | May 27, 2022 | |
| 2021 | Jun 1, 2021 | |
| 2020 | May 5, 2020 | |
| 2019 | May 8, 2019 | |
| 2018 | May 14, 2018 | |
| 2017 | May 30, 2017 | |
| 2016 | Jun 15, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.